Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-049049
Filing Date
2010-03-05
Accepted
2010-03-05 17:01:27
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1216817
2 FORM OF RSU GRANT AGREEMENT dex1039.htm EX-10.39 42009
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1638
4 CERTIFICATION OF PEO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 9855
5 CERTIFICATION OF PFO REQUIRED UNDER RULES 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 9932
6 CERTIFICATION OF PEO AND PFO REQUIRED UNDER RULE 13A-14(B) dex321.htm EX-32.1 5953
7 GRAPHIC g31291g16j59.jpg GRAPHIC 50086
  Complete submission text file 0001193125-10-049049.txt   1356757
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-33719 | Film No.: 10661422
SIC: 2834 Pharmaceutical Preparations